COMPANY PROFILE

Peplin

Explore full profile

Specialty pharmaceutical company focused on advancing and commercializing medical dermatology products

Emeryville, United StatesFounded 1998Biotech & Life Sciences

Valuation $250–500M Last recorded · 2009

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Peplin

LEO Pharma, founded in 1908 and headquartered in Denmark, specializes in dermatology solutions aimed at improving skin health. Serving clients in over 130 countries, the company employs 6,000 professionals across 60 countries. LEO Pharma operates in the pharmaceutical market, focusing on developing, manufacturing, and marketing dermatological treatments. The business model revolves around research and development, producing innovative treatments, and generating revenue through the sale of these products. The company reinvests in knowledge and innovation to maintain its leadership in the dermatology sector.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 1998
Headquarters: Emeryville, United States
Employees: 15
Open positions: None listed
Dealroom signal: 53.9/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GROWTH EQUITY VCEquity / VC	Aug 2014	$0	—	BioScience Managers Limited	↗
ACQUISITION✓Exit	Sep 2009	$288M	$288M	LEO pharma	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Peplin website traffic

Latest recorded traffic for Peplin is 0 monthly website visits. Peplin's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%

Monthly website visitsNov 2018–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VOVodorasloYour solution to better air quality	Sofia, Bulgaria	Operational	1	$61K	$132K
NBNormax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness	Cork, Ireland	Operational
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
LTLTZ TherapeuticsDevelops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need	Redwood City, United States	Operational
TBTome BiosciencesTome Biosciences is the programmable gene insertion company	Watertown, United States	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
TTTeitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases	Aarhus, Denmark	Operational
DEDevelogenA biology-driven drug discovery company developing novel therapies for diabetes and obesity	Göttingen, Germany	Acquired